{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:34Z","timestamp":1791397354751,"version":"4.3.3"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T00:00:00Z","timestamp":1358640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12016-012-8351-x","type":"journal-article","created":{"date-parts":[[2013,1,19]],"date-time":"2013-01-19T05:29:23Z","timestamp":1358573363000},"page":"202-210","source":"Crossref","is-referenced-by-count":118,"title":["Autoinflammatory Skin Disorders in Inflammatory Bowel Diseases, Pyoderma Gangrenosum and Sweet\u2019s Syndrome: a Comprehensive Review and Disease Classification Criteria"],"prefix":"10.1007","volume":"45","author":[{"given":"Angelo V.","family":"Marzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim S.","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Saibeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Crosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,20]]},"reference":[{"key":"8351_CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11310730-000000000-00000","volume":"10","author":"PR Cohen","year":"2009","unstructured":"Cohen PR (2009) Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 10:301\u2013312","journal-title":"Am J Clin Dermatol"},{"key":"8351_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","volume":"13","author":"I Ahronowitz","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K (2012) Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 13:191\u2013211","journal-title":"Am J Clin Dermatol"},{"key":"8351_CR3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/09546631003686069","volume":"22","author":"AV Marzano","year":"2011","unstructured":"Marzano AV, Trevisan V, Lazzari R, Crosti C (2011) Pyoderma gangrenosum: study of 21 patients and proposal of a \u2018clinicotherapeutic\u2019 classification. J Dermatol Treat 22:254\u2013260","journal-title":"J Dermatol Treat"},{"key":"8351_CR4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ajpath.2010.12.035","volume":"178","author":"AB Nesterovitch","year":"2011","unstructured":"Nesterovitch AB, Gyorfy Z, Hoffman MD, Moore EC, Elbuluk N, Tryniszewska B, Rauch TA, Simon M, Kang S, Fisher GJ, Mikecz K, Tharp MD, Glant TT (2011) Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6\/SHP1) may contribute to neutrophilic dermatoses. Am J Pathol 178:1434\u20131441","journal-title":"Am J Pathol"},{"key":"8351_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrrheum.2011.94","volume":"7","author":"I Aksentijevich","year":"2011","unstructured":"Aksentijevich I, Kastner DL (2011) Genetics of monogenic autoinflammatory diseases: past successes, future challenges. Nat Rev Rheumatol 7:469\u201378","journal-title":"Nat Rev Rheumatol"},{"key":"8351_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O'Shea JJ, Kastner DL (1999) Germline mutations in the extracellular domains of the 55\u00a0kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133\u2013144","journal-title":"Cell"},{"key":"8351_CR7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784\u201390","journal-title":"Cell"},{"key":"8351_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2012.07.018","volume":"12","author":"A Doria","year":"2012","unstructured":"Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, Ghirardello A, Iaccarino L, Punzi L (2012) Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12:22\u201330","journal-title":"Autoimmun Rev"},{"key":"8351_CR9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","volume":"11","author":"CA Wise","year":"2002","unstructured":"Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961\u20139","journal-title":"Hum Mol Genet"},{"key":"8351_CR10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/eji.201141550","volume":"41","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA (2011) A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation. Eur J Immunol 41:1203\u20131217","journal-title":"Eur J Immunol"},{"key":"8351_CR11","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066\u20132078","journal-title":"N Engl J Med"},{"key":"8351_CR12","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","volume":"12","author":"KS Rothfuss","year":"2006","unstructured":"Rothfuss KS, Stange EF, Herrlinger KR (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 12:4819\u20134831","journal-title":"World J Gastroenterol"},{"key":"8351_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","volume":"42","author":"S Larsen","year":"2010","unstructured":"Larsen S, Bendtzen K, Nielsen OH (2010) Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 42:97\u2013114","journal-title":"Ann Med"},{"key":"8351_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00128071-200203030-00002","volume":"3","author":"U Wollina","year":"2002","unstructured":"Wollina U (2002) Clinical management of pyoderma gangrenosum. Am J Clin Dermatol 3:149\u2013158","journal-title":"Am J Clin Dermatol"},{"key":"8351_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","volume":"34","author":"FC Powell","year":"1996","unstructured":"Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34:395\u2013409, quiz 410\u2013392","journal-title":"J Am Acad Dermatol"},{"key":"8351_CR16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"JP Callen","year":"1996","unstructured":"Callen JP (1996) Pyoderma gangrenosum. Lancet 351:581\u2013585","journal-title":"Lancet"},{"key":"8351_CR17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1684\/ejd.2012.1776","volume":"22","author":"AV Marzano","year":"2012","unstructured":"Marzano AV, Ishak RS, Lazzari R, Polloni I, Vettoretti S, Crosti C (2012) Vulvar pyoderma gangrenosum with renal involvement. Eur J Dermatol 22:537\u2013539","journal-title":"Eur J Dermatol"},{"key":"8351_CR18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","volume":"23","author":"E Ruocco","year":"2009","unstructured":"Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G (2009) Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 23:1008\u20131017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8351_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","volume":"162","author":"AV Marzano","year":"2010","unstructured":"Marzano AV, Cugno M, Trevisan V, Fanoni D, Venegoni L, Berti E, Crosti C (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162:100\u2013107","journal-title":"Clin Exp Immunol"},{"key":"8351_CR20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.1978.01640190049017","volume":"114","author":"S O'Loughlin","year":"1978","unstructured":"O'Loughlin S, Perry HO (1978) A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol 114:1061\u20131064","journal-title":"Arch Dermatol"},{"key":"8351_CR21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","volume":"43","author":"WP Su","year":"2004","unstructured":"Su WP, Davis MD, Weenig RH, Powell FC, Perry HO (2004) Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43:790\u2013800","journal-title":"Int J Dermatol"},{"key":"8351_CR22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1610-0387.2005.05022.x","volume":"3","author":"C Conrad","year":"2005","unstructured":"Conrad C, Trueb RM (2005) Pyoderma gangrenosum. J Dtsch Dermatol Ges 3:334\u2013342","journal-title":"J Dtsch Dermatol Ges"},{"key":"8351_CR23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archderm.1972.01620150083026","volume":"106","author":"HO Perry","year":"1972","unstructured":"Perry HO, Winkelmann RK (1972) Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 106:901\u2013905","journal-title":"Arch Dermatol"},{"key":"8351_CR24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2340\/00015555-0346","volume":"88","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Trevisan V, Galloni C, Alessi E (2008) Fatal bullous pyoderma gangrenosum in a patient with Klinefelter\u2019s syndrome. Acta Derm Venereol 88:158\u2013159","journal-title":"Acta Derm Venereol"},{"key":"8351_CR25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0190-9622(88)70074-2","volume":"18","author":"E Wilson-Jones","year":"1988","unstructured":"Wilson-Jones E, Winkelmann RK (1988) Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 18:511\u2013521","journal-title":"J Am Acad Dermatol"},{"key":"8351_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2230.2007.02607.x","volume":"33","author":"AV Marzano","year":"2008","unstructured":"Marzano AV, Tourlaki A, Alessi E, Caputo R (2008) Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Clin Exp Dermatol 33:156\u2013159","journal-title":"Clin Exp Dermatol"},{"key":"8351_CR27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1067\/mjd.2000.104515","volume":"42","author":"CC Lyon","year":"2000","unstructured":"Lyon CC, Smith AJ, Beck MH, Wong GA, Griffiths CE (2000) Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 42:992\u20131002","journal-title":"J Am Acad Dermatol"},{"key":"8351_CR28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/BF02052602","volume":"37","author":"JJ Tjandra","year":"1994","unstructured":"Tjandra JJ, Hughes LE (1994) Parastomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 37:938\u2013942","journal-title":"Dis Colon Rectum"},{"key":"8351_CR29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-4362.2003.01891.x","volume":"42","author":"PR Cohen","year":"2003","unstructured":"Cohen PR, Kurzrock R (2003) Sweet\u2019s syndrome revisited: a review of disease concepts. Int J Dermatol 42:761\u2013778","journal-title":"Int J Dermatol"},{"key":"8351_CR30","first-page":"199","volume":"39","author":"PR Cohen","year":"1989","unstructured":"Cohen PR, Almeida L, Kurzrock R (1989) Acute febrile neutrophilic dermatosis. Am Fam Physician 39:199\u2013204","journal-title":"Am Fam Physician"},{"key":"8351_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/00015550260132604","volume":"82","author":"O Carpentier","year":"2002","unstructured":"Carpentier O, Piette F, Delaporte E (2002) Sweet\u2019s syndrome after BCG vaccination. Acta Derm Venereol 82:221","journal-title":"Acta Derm Venereol"},{"key":"8351_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<126::AID-AJH9>3.0.CO;2-8","volume":"61","author":"KR Arbetter","year":"1999","unstructured":"Arbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL (1999) Case of granulocyte colony-stimulating factor-induced Sweet\u2019s syndrome. Am J Hematol 61:126\u2013129","journal-title":"Am J Hematol"},{"key":"8351_CR33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.140.5.570","volume":"140","author":"T Kawakami","year":"2004","unstructured":"Kawakami T, Ohashi S, Kawa Y, Takahama H, Ito M, Soma Y, Mizoguchi M (2004) Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol 140:570\u2013574","journal-title":"Arch Dermatol"},{"key":"8351_CR34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.20112","volume":"76","author":"G Kumar","year":"2004","unstructured":"Kumar G, Bernstein JM, Waibel JS, Baumann MA (2004) Sweet\u2019s syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol 76:283\u2013285","journal-title":"Am J Hematol"},{"key":"8351_CR35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1365-2133.2004.06007.x","volume":"150","author":"O Dereure","year":"2004","unstructured":"Dereure O, Hillaire-Buys D, Guilhou JJ (2004) Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome? Br J Dermatol 150:1228\u20131230","journal-title":"Br J Dermatol"},{"key":"8351_CR36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen PR (2007) Sweet\u2019s syndrome: a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34","journal-title":"Orphanet J Rare Dis"},{"key":"8351_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0738-081X(99)00129-7","volume":"18","author":"PR Cohen","year":"2000","unstructured":"Cohen PR, Kurzrock R (2000) Sweet\u2019s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18:265\u2013282","journal-title":"Clin Dermatol"},{"key":"8351_CR38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2133.2006.07677.x","volume":"156","author":"CY Neoh","year":"2007","unstructured":"Neoh CY, Tan AW, Ng SK (2007) Sweet\u2019s syndrome: a spectrum of unusual clinical presentations and associations. Br J Dermatol 156:480\u2013485","journal-title":"Br J Dermatol"},{"key":"8351_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0001-7310(05)75062-6","volume":"96","author":"S Bielsa","year":"2005","unstructured":"Bielsa S, Baradad M, Marti RM, Casanova JM (2005) Sweet\u2019s syndrome with bullous lesions. Actas Dermosifiliogr 96:315\u2013316","journal-title":"Actas Dermosifiliogr"},{"key":"8351_CR40","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1365-4632.2004.02287.x","volume":"44","author":"S Voelter-Mahlknecht","year":"2005","unstructured":"Voelter-Mahlknecht S, Bauer J, Metzler G, Fierlbeck G, Rassner G (2005) Bullous variant of Sweet\u2019s syndrome. Int J Dermatol 44:946\u2013947","journal-title":"Int J Dermatol"},{"key":"8351_CR41","doi-asserted-by":"crossref","unstructured":"Sommer S, Wilkinson SM, Merchant WJ, Goulden V (2000) Sweet\u2019s syndrome presenting as palmoplantar pustulosis. J Am Acad Dermatol 42:332\u2013334","DOI":"10.1016\/S0190-9622(00)90105-1"},{"key":"8351_CR42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jaad.2005.03.001","volume":"52","author":"PR Cohen","year":"2005","unstructured":"Cohen PR (2005) Subcutaneous Sweet\u2019s syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol 52:927\u2013928","journal-title":"J Am Acad Dermatol"},{"key":"8351_CR43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2133.1964.tb14541.x","volume":"76","author":"RD Sweet","year":"1964","unstructured":"Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76:349\u2013356","journal-title":"Br J Dermatol"},{"key":"8351_CR44","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archderm.1983.01650310072016","volume":"119","author":"PH Cooper","year":"1983","unstructured":"Cooper PH, Frierson HF, Greer KE (1983) Subcutaneous neutrophilic infiltrates in acute febrile neutrophilic dermatosis. Arch Dermatol 119:610\u2013611","journal-title":"Arch Dermatol"},{"key":"8351_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-0960.1991.tb00063.x","volume":"32","author":"J Cullity","year":"1991","unstructured":"Cullity J, Maguire B, Gebauer K (1991) Sweet\u2019s panniculitis. Australas J Dermatol 32:61\u201364","journal-title":"Australas J Dermatol"},{"key":"8351_CR46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2133.1995.tb02684.x","volume":"133","author":"Y Suzuki","year":"1995","unstructured":"Suzuki Y, Kuroda K, Kojima T, Fujita M, Iseki T, Shinkai H (1995) Unusual cutaneous manifestations of myelodysplastic syndrome. Br J Dermatol 133:483\u2013486","journal-title":"Br J Dermatol"},{"key":"8351_CR47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0738-081X(93)90112-P","volume":"11","author":"PR Cohen","year":"1993","unstructured":"Cohen PR, Kurzrock R (1993) Sweet\u2019s syndrome and cancer. Clin Dermatol 11:149\u2013157","journal-title":"Clin Dermatol"},{"key":"8351_CR48","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9343(87)90229-4","volume":"82","author":"PR Cohen","year":"1987","unstructured":"Cohen PR, Kurzrock R (1987) Sweet\u2019s syndrome and malignancy. Am J Med 82:1220\u20131226","journal-title":"Am J Med"},{"key":"8351_CR49","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1572-0241.2006.00552.x","volume":"101","author":"I Vind","year":"2006","unstructured":"Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, N\u00f8rregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group (2006) Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003\u20132005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 101:1274\u20131282","journal-title":"Am J Gastroenterol"},{"key":"8351_CR50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106:110\u2013119","journal-title":"Am J Gastroenterol"},{"key":"8351_CR51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11894-008-0108-6","volume":"10","author":"H Williams","year":"2008","unstructured":"Williams H, Walker D, Orchard TR (2008) Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 10:597\u2013605","journal-title":"Curr Gastroenterol Rep"},{"key":"8351_CR52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.det.2008.05.014","volume":"26","author":"L Requena","year":"2008","unstructured":"Requena L, Yus ES (2008) Erythema nodosum. Dermatol Clin 26:425\u2013438","journal-title":"Dermatol Clin"},{"key":"8351_CR53","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","volume":"11","author":"S Danese","year":"2005","unstructured":"Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11:7227\u20137236","journal-title":"World J Gastroenterol"},{"key":"8351_CR54","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:1116\u20131122","journal-title":"Am J Gastroenterol"},{"key":"8351_CR55","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/pgmj.2004.031633","volume":"81","author":"LB Trost","year":"2005","unstructured":"Trost LB, McDonnell JK (2005) Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 81:580\u2013585","journal-title":"Postgrad Med J"},{"key":"8351_CR56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.21.3.247","volume":"21","author":"JR Thornton","year":"1980","unstructured":"Thornton JR, Teague RH, Low-Beer TS, Read AE (1980) Pyoderma gangrenosum and ulcerative colitis. Gut 21:247\u2013248","journal-title":"Gut"},{"key":"8351_CR57","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/bjs.1800780613","volume":"78","author":"MD Levitt","year":"1991","unstructured":"Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RK (1991) Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 78:676\u2013678","journal-title":"Br J Surg"},{"key":"8351_CR58","first-page":"88","volume":"6","author":"Y Menachem","year":"2004","unstructured":"Menachem Y, Gotsman I (2004) Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Isr Med Assoc J 6:88\u201390","journal-title":"Isr Med Assoc J"},{"key":"8351_CR59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000050097","volume":"18","author":"P Goudet","year":"2001","unstructured":"Goudet P, Dozois RR, Kelly KA, Ilstrup DM, Phillips SF (2001) Characteristics and evolution of extraintestinal manifestations associated with ulcerative colitis after proctocolectomy. Dig Surg 18:51\u201355","journal-title":"Dig Surg"},{"key":"8351_CR60","first-page":"615","volume":"80","author":"SH Mir-Madjlessi","year":"1985","unstructured":"Mir-Madjlessi SH, Taylor JS, Farmer RG (1985) Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 80:615\u2013620","journal-title":"Am J Gastroenterol"},{"key":"8351_CR61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/09546630903268239","volume":"21","author":"AV Marzano","year":"2010","unstructured":"Marzano AV, Trevisan V, Lazzari R, Crosti C (2010) Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum. J Dermatol Treat 21:140\u2013143","journal-title":"J Dermatol Treat"},{"key":"8351_CR62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.clindermatol.2007.10.018","volume":"26","author":"S Timani","year":"2008","unstructured":"Timani S, Mutasim DF (2008) Skin manifestations of inflammatory bowel disease. Clin Dermatol 26:265\u2013273","journal-title":"Clin Dermatol"},{"key":"8351_CR63","first-page":"13","volume":"3","author":"BL Huang","year":"2012","unstructured":"Huang BL, Chandra S, Shih DQ (2012) Skin manifestations of inflammatory bowel disease. Front Physiol 3:13","journal-title":"Front Physiol"},{"key":"8351_CR64","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-4362.1992.tb02728.x","volume":"31","author":"V Wasserteil","year":"1992","unstructured":"Wasserteil V, Bruce S, Sessoms SL, Guntupalli KK (1992) Pyoderma gangrenosum treated with hyperbaric oxygen therapy. Int J Dermatol 31:594\u2013596","journal-title":"Int J Dermatol"},{"key":"8351_CR65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, Forbes A, Greenwood R, Probert CS (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55:505\u2013509","journal-title":"Gut"},{"key":"8351_CR66","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ibd.20748","volume":"15","author":"N Alkhouri","year":"2009","unstructured":"Alkhouri N, Hupertz V, Mahajan L (2009) Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn\u2019s disease. Inflamm Bowel Dis 15:803\u2013806","journal-title":"Inflamm Bowel Dis"},{"key":"8351_CR67","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archdermatol.2011.168","volume":"147","author":"E Guenova","year":"2011","unstructured":"Guenova E, Teske A, Fehrenbacher B, Hoerber S, Adamczyk A, Schaller M, Hoetzenecker W, Biedermann T (2011) Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol 147:1203\u20131205","journal-title":"Arch Dermatol"},{"key":"8351_CR68","first-page":"1","volume":"16","author":"A Vij","year":"2010","unstructured":"Vij A, Modi GM, Suwattee P, Cockerell CJ, Hsu S (2010) Chronic, recurrent neutrophilic dermatosis: a case report. Dermatol Online J 16:1","journal-title":"Dermatol Online J"},{"key":"8351_CR69","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0190-9622(90)70250-L","volume":"23","author":"D Kemmett","year":"1990","unstructured":"Kemmett D, Hunter JA (1990) Sweet\u2019s syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol 23:503\u2013507","journal-title":"J Am Acad Dermatol"},{"key":"8351_CR70","first-page":"49","volume":"85","author":"A Souissi","year":"2007","unstructured":"Souissi A, Benmously R, Fenniche S, Zarrouk M, Marrek H, Debbiche A, Ayed MB, Mokhtar I (2007) Sweet\u2019s syndrome: a propos of 8 cases. Tunis Med 85:49\u201353","journal-title":"Tunis Med"},{"key":"8351_CR71","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/bmj.297.6662.1513-a","volume":"297","author":"D Kemmett","year":"1988","unstructured":"Kemmett D, Gawkrodger DJ, Wilson G, Hunter JA (1988) Sweet\u2019s syndrome in Crohn\u2019s disease. BMJ 297:1513\u20131514","journal-title":"BMJ"},{"key":"8351_CR72","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.dld.2003.10.020","volume":"36","author":"OA Paoluzi","year":"2004","unstructured":"Paoluzi OA, Crispino P, Amantea A, Pica R, Iacopini F, Consolazio A, Di Palma V, Rivera M, Paoluzi P (2004) Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet\u2019s syndrome. Case report and review of literature. Dig Liver Dis 36:361\u2013366","journal-title":"Dig Liver Dis"},{"key":"8351_CR73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2230.1995.tb01324.x","volume":"20","author":"NP Burrows","year":"1995","unstructured":"Burrows NP (1995) Sweet\u2019s syndrome in association with Crohn\u2019s disease. Clin Exp Dermatol 20:279\u2013280","journal-title":"Clin Exp Dermatol"},{"key":"8351_CR74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000088466","volume":"72","author":"H Ytting","year":"2005","unstructured":"Ytting H, Vind I, Bang D, Munkholm P (2005) Sweet\u2019s syndrome\u2014an extraintestinal manifestation in inflammatory bowel disease. Digestion 72:195\u2013200","journal-title":"Digestion"},{"issue":"Suppl 2","key":"8351_CR75","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","volume":"40","author":"S Ardizzone","year":"2008","unstructured":"Ardizzone S, Puttini PS, Cassinotti A, Porro GB (2008) Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 40(Suppl 2):S253\u2013259","journal-title":"Dig Liver Dis"},{"key":"8351_CR76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2230.1996.tb00054.x","volume":"21","author":"A Darvay","year":"1996","unstructured":"Darvay A (1996) Sweet\u2019s syndrome preceding inflammatory bowel disease. Clin Exp Dermatol 21:175","journal-title":"Clin Exp Dermatol"},{"key":"8351_CR77","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00042737-199707000-00013","volume":"9","author":"S Travis","year":"1997","unstructured":"Travis S, Innes N, Davies MG, Daneshmend T, Hughes S (1997) Sweet\u2019s syndrome: an unusual cutaneous feature of Crohn\u2019s disease or ulcerative colitis. The South West Gastroenterology Group. Eur J Gastroenterol Hepatol 9:715\u2013720","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8351_CR78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","volume":"55","author":"AJ Greenstein","year":"1976","unstructured":"Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55:401\u2013412","journal-title":"Medicine (Baltimore)"},{"key":"8351_CR79","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1200\/JCO.1988.6.12.1887","volume":"6","author":"PR Cohen","year":"1988","unstructured":"Cohen PR, Talpaz M, Kurzrock R (1988) Malignancy-associated Sweet\u2019s syndrome: review of the world literature. J Clin Oncol 6:1887\u20131897","journal-title":"J Clin Oncol"},{"key":"8351_CR80","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1155\/2008\/960585","volume":"22","author":"M Ali","year":"2008","unstructured":"Ali M, Duerksen DR (2008) Ulcerative colitis and Sweet's syndrome: a case report and review of the literature. Can J Gastroenterol 22:296\u2013298","journal-title":"Can J Gastroenterol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8351-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-012-8351-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8351-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T18:58:12Z","timestamp":1595271492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-012-8351-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,20]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["8351"],"URL":"https:\/\/doi.org\/10.1007\/s12016-012-8351-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,20]]}}}